109263 ⎘
Specific components of cell culture medium; Undefined extracts from bacteria
COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS
#2COMPOSITIONS HAVING HIGH PROTEIN CONTENT
#3producing tetrodotoxin and application thereof
#4COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS
#5METHOD FOR INCREASING FERROUS ION CONTENT IN BACILLUS COAGULANS AND COMPOUND MICROBIAL AGENT
#6METHOD FOR THE PRODUCTION OF MATURE DENDRITIC CELLS IN VITRO USING A BACTERIAL LYSATE
#7METHOD FOR PROMOTING GROWTH OF GAS-FERMENTED MICROORGANISMS
#8Target-primed macrophages and therapeutic uses thereof
#9PROCESS FOR REDUCING THE ACTIVITY OF MICROBIAL CONTAMINATION IN A YEAST MEDIUM
#10Microorganism-Derived Protein Hydrolysates and Methods of Preparation and Use Thereof
#11METHOD FOR PRODUCING CELL AGGREGATES
#12Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
#13Composite shell particle, biological material, and method of manufacturing composite shell particle
#14SINGLE B-CELL CULTIVATION METHOD
#15CELL AGGREGATION SUPPRESSOR
#16Methods of cultivating species
#17Composite shell particle, biological material, and method of manufacturing composite shell particle
#18COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS
#19-activated B cell platforms and methods thereof
#20Ex vivo antigen and adjuvant pulsed peripheral blood mononuclear cells as a screening platform for candidate novel vaccines and candidate antigens
#21METHOD FOR PREPARING CORNEAL TISSUE
#22METHODS RELATING TO ACTIVATED DENDRITIC CELL COMPOSITIONS AND IMMUNOTHERAPEUTIC TREATMENTS FOR SUBJECTS WITH ADVANCED CANCERS
#23SINGLE B-CELL CULTIVATION METHOD
#24ORGANOTYPIC LUNG MODEL WITH FUNCTIONAL IMMUNE CELLS
#25-activated B cell platforms and methods thereof
#26Method for inducing cell reprogramming, and method for producing pluripotent cells
#27METHOD FOR PRODUCING CELL AGGREGATES
#28Strain of and its metabolites for use in inhibiting xanthine oxidase and treating gout
#29Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
#30Sulfated depolymerized derivatives of exopolysaccharides (EPS) from mesophilic marine bacteria, method for preparing same, and uses thereof in tissue regeneration
#31Cell culture of corneal endothelial cells
#32COMPOSITIONS AND METHODS FOR ENHANCING MOBILIZATION AND PROLIFERATION OF BLASTOMERE-LIKE STEM CELLS
#33Composition for maturing dendritic cells, and method for preparing antigen-specific dendritic cells using same
#34Method for producing pluripotent cell using bacterium having fermentation ability
#35Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
#36METHOD FOR PRODUCING NK CELL-ENRICHED BLOOD PRODUCT
#37ADMINISTRATION OF DENDRITIC CELLS PARTIALLY MATURED IN VITRO FOR THE TREATMENT OF TUMORS
#38Process for production of natural killer cells
#39Chimera comprising bacterial cytotoxin and methods of using the same
#40Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
#41Sulfated depolymerized derivatives of expolysaccharides (EPS) from mesophilic marine bacteria, method for preparing the same, and uses thereof in tissue regeneration
#42Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
#43INDUCTION OF DENDRITIC CELL DEVELOPMENT WITH MACROPHAGE-COLONY STIMULATING FACTOR (M-CSF) RECEPTOR LIGANDS
#44Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
#45COMPOSITIONS AND METHODS FOR PRIMING MONOCYTIC DENDRITIC CELLS AND T CELLS FOR TH-1 RESPONSE
#46Sulfated Depolymerized Derivatives of Exopolysaccharides (Eps) from Mesophilic Marine Bacteria, Method for Preparing Same, and Uses Thereof in Tissue Regeneration
#47Use of low-molecular-weight highly sulfated polysaccharide derivatives for modulating angiogenesis
#48Use of esters of unsaturated, physiologically active fatty acids as nutrient media for cell cultures
#49Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells
#50Administration of dendritic cells partially matured in vitro for the treatment of tumors
#51Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells
#52Compositions and methods for priming monocytic dendritic cells and t cells for th-1response
#53Generation of human regulatory T cells by bacterial toxins for the treatment of inflammatory disorders